AKERO THERAPEUTICS INC's ticker is AKRO and the CUSIP is 00973Y108. A total of 69 filers reported holding AKERO THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 1.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $19,532,000 | +19.5% | 673,280 | +6.3% | 0.69% | -5.9% |
| Q4 2020 | $16,342,000 | -7.2% | 633,426 | +10.8% | 0.73% | -28.4% |
| Q3 2020 | $17,607,000 | +19.5% | 571,833 | -3.3% | 1.02% | -3.6% |
| Q2 2020 | $14,732,000 | -14.0% | 591,169 | -26.9% | 1.06% | -32.0% |
| Q1 2020 | $17,135,000 | – | 808,247 | – | 1.55% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ATP Life Science Ventures, L.P. | 5,830,203 | $168,435,000 | 13.00% |
| venBio Partners LLC | 2,444,311 | $63,063,000 | 5.57% |
| Versant Venture Management, LLC | 777,727 | $20,065,000 | 2.08% |
| Vivo Capital, LLC | 633,426 | $16,342,000 | 0.73% |
| Redmile Group, LLC | 2,322,557 | $59,922,000 | 0.73% |
| Boxer Capital, LLC | 831,495 | $21,453,000 | 0.69% |
| Integral Health Asset Management, LLC | 85,000 | $2,193,000 | 0.65% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 35,179 | $908,000 | 0.53% |
| HighVista Strategies LLC | 27,739 | $716,000 | 0.46% |
| Cormorant Asset Management, LP | 742,549 | $19,158,000 | 0.46% |